Thus, our results demonstrated the relationship between E-cadherin loss, induced by TGF-β1 treatment, and biomechanical properties of the breast cancer cells: changes in morphometry, cytoskeletal architecture, elasticity, and migratory capacity suggested the important role of TGF-β1 in the early steps of EMT. Here, TGFB1 is linked to breast cancer.